The abstract is read at the publisher; the summary is JClub's.
Cancer cachexia is a tumor-driven systemic metabolic syndrome marked by skeletal muscle atrophy and adipose tissue loss, linked to poor survival across multiple malignancies.
- Why it matters: It causes functional decline, reduced quality of life, impaired treatment tolerance, and worse survival, yet effective therapies remain limited due to incomplete mechanistic understanding and lack of integrated clinical frameworks.
- What they did: The review synthesizes recent findings on tumor-host signaling, multiorgan metabolic remodeling, and neuroendocrine regulation, emphasizing dynamic interactions among immune, metabolic, endocrine, and neural networks.
- The result: A tumor-centric framework is proposed to describe cachexia as a progressive collapse of systemic homeostasis, aiming to guide mechanism-informed translational therapeutic strategies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.